LogiPharma, Main Conference Day One: Supply Chain Planning & Optimisation Distribution Strategies.

08.00 Registration and refreshments Registration and refreshments

08.45 Conference director welcome and LogiPharma strategic outlook Tarley Cameron, Conference Director, Worldwide Business Research Conference director welcome and LogiPharma strategic outlook Tarley Cameron Conference Director, Worldwide Business Research Tarley directs the Pharmaceutical Supply Chain portfolio at Worldwide Business Research (WBR). Within this role Tarley is responsible for P&L across a number of prominent large scale conference brands, project leading a team of sales, marketing and operations to deliver a high-level, profitable product. LogiPharma, the largest and most respected event of its kind, attracts in exces [read more]

08.50 Chairperson's opening remarks Jacques Le Ny, Partner, Infosys Lodestone Chairperson's opening remarks Jacques Le Ny Partner, Infosys Lodestone Jacques’s is specialized in supply chain planning & collaboration. He holds a master degree in information processing and started his career during 5 years in the high tech industry as a qualified electronics engineer before becoming a consultant specialized in manufacturing, just-in-time and logistics. He then focused on supply chain planning with various technologies, Numetrix, M [read more]

09.00 Keynote opening address: Designing a world-class supply chain: Balancing risks and opportunities Carlo de Notaristefani, President and Chief Executive Officer of Global Operations, Teva Pharmaceutical Industries Striking a balance between the mission-critical obligation to patients and responsibility to shareholders, healthcare systems and regulatory bodies Levers to foster productivity and efficiencies: turning complexity into an opportunity Segment optimisation drives supply chain design Building in the needs of an innovative product portfolio into a network overwhelmingly focused on supplying generics Carlo de Notaristefani President and Chief Executive Officer of Global Operations, Teva Pharmaceutical Industries Carlo de Notaristefani is President and CEO of Global Operations at Teva Pharmaceuticals Ltd. where he is a member of Teva’s Executive Committee. He is responsible for supply chain operations and the procurement organization.Prior to joining Teva, Carlo was a member of the Senior Management Team at Bristol-Myers Squibb and President of Technical Operations and Global Support Functions, with respon [read more]

09.35 Case Study: Enhancing collaboration and integration across the total supply network: Where innovation from outside industries can advance the Pharma industry effectiveness Alessandro De Luca, SVP, Head of Global Supply Network Operations, Merck Group Paolo Rosanna, VP Head of Business Development, Life Sciences & Healthcare EMEA , DHL Supply Chain Myths and realities of the FMCG supply chain Pharma supply network: the value of enhancing collaboration and integration Designing the "last mile" together Alessandro De Luca SVP, Head of Global Supply Network Operations, Merck Group Alessandro has a degree in Nuclear Engineering and one in Civil Engineering both held at Rome University, La Sapienza.He is currently Senior Vice President, head of Supply Network Operations, in Merck Serono, a company belonging to the MerckGroup. He holds this position since August 2012. In 2011, he has joined Merck Serono as VP, head of Global Supply Chain.Previously, Alessandro has worked for m [read more] Paolo Rosanna VP Head of Business Development, Life Sciences & Healthcare EMEA , DHL Supply Chain Paolo Rosanna was appointed VP, Head of Business Development in January 2012 to lead the Business Development agenda for the Life Sciences & Healthcare Sector in EMEA. Following his degree in Business Administration with a major in Marketing at the Università Commerciale Luigi Bocconi of Milan, Paolo started his career in international Freight Forwarding in the UK, USA and Italy wi [read more]

10.10 Pharma Supply chain 2020 - shaping business opportunities Thomas Ebel, Principal , McKinsey & Company, Inc. Pharma vs. other industries: performance baseline and aspiration Agility: new muscle for global supply chains Segmentation and postponement: unleashing the power Route-to-market strategies: innovating ways to the patient Up and downstream collaboration: what is the next frontier for pharma? Thomas Ebel Principal , McKinsey & Company, Inc. Thomas Ebel is a Partner in McKinsey's global Pharmaceutical Operations practice and the European Supply chain practice, located in the Düsseldorf office. He supports companies in Pharmaceuticals and Consumer goods in transforming their end-to-end supply chains, optimizing service, working capital, and total cost of supply, as well as building the right capabilities to support growth and profitabi [read more]

Morning refreshments and networkingSpeakers Corner 10.45 Morning refreshments and networking Morning refreshments and networking Morning refreshments and networking 10.45 Speakers Corner Speakers Corner An area dedicated to interaction with the previous session’s speakers and panellists. This is your opportunity to network and speak openly and candidly about any questions not covered during their session.

Stream A: Planning & optimisation Stream B: Distribution & network d...Stream C: Supply chain leadership &... 11.15 Thinking ahead: The future of planning and S&OP Stream A: Planning & optimisation Andy Evans, Head of Global Supply Chain Planning, AstraZeneca Michael Jarosch, Partner, Camelot Management Consultants AG Today's S&OP set up will often not support and provide the new required decision making capabilities. This session will give you: Undisputed S&OP objectives and trends that will challenge your S&OP effectiveness Do we need a faster "clock speed" for S&OP? Required step changes in your analytics & simulation capabilities The framewoks for Central command & control or coordination of networks Andy Evans Head of Global Supply Chain Planning, AstraZeneca Andy has worked in AZ for 25 years (through ICI, Zeneca and then AstraZeneca) joining originally as a Chemical Engineer and have worked across all parts of the supply chain. In his early career Andy held a variety of Engineering and Production Management roles which included working in France. More recent roles have including Global Supply Chain Manager, Engineering Manager for an API site undergo [read more] Michael Jarosch Partner, Camelot Management Consultants AG Michael Jarosch joined Camelot Management Consultants in 2008 leading the Pharma and Medical Devices industry line of business and is a member of the management team at Camelot. Prior to Camelot he had positions as Vice President for Ernst & Young/Cap Gemini and as a Partner at Unisys.Michael is a top management consultant with more than 20 years of extensive experience in strategy [read more] 11.15 Panel debate: Dubai as a regional pharmaceutical hub: leveraging opportunities and growth across the Middle East Stream B: Distribution & network design Philippe Francois, VP, Supply Chain EMEA, Baxter Healthcare Valgeir Petursson, Director Logistics, Actavis Manel Luis, Director Business Solutions EMEA, Pfizer Mohammed Esa, CEO, Dubai and SVP, UAE, Oman & Bahrain, Agility Logistics Leif Kronkvist, Business Development Vice President, Agility Logistics Panel debate: Dubai as a regional pharmaceutical hub: leveraging opportunities and growth across the Middle East Moderator: Mohammed Esa Philippe Francois VP, Supply Chain EMEA, Baxter Healthcare Philippe Francois is currently the Supply Chain vice president for Baxter healthcare for the Europe Middle East and Africa region He holds a master degree in engineering and an MBA and started his career in the automotive industry in France where he acquired a solid experience in Just in time techniques. He joined the healthcare industry where he has been working for the last 15 years and acquire [read more] Valgeir Petursson Director Logistics, Actavis For the best part of 17 years Val Petursson spent his time within a Global Supply Chain function, the last 7 within the Medical and Pharmaceutical sector. Since Jan 2012, Val´s role has been to transform Actavis logistics into a state of art function, which is an exciting 3 year journey. In Nov 2012 – with the merger of Watson and Actavis – Val became responsible for International Logistics for th [read more] Manel Luis Director Business Solutions EMEA, Pfizer Manel Luis is the Director Business Solutions for EMEA at Global Logistics and Supply Division at Pfizer’s subsidiary in Brussels. He has been with the company for the last eight years working in different locations (Spain, Italy & Belgium), after spending two years as a consultant at A.T.Kearney. During his career Manel has taken both Operations roles (managing the SC function in [read more] Mohammed Esa CEO, Dubai and SVP, UAE, Oman & Bahrain, Agility Logistics Mohammed Esa is Agility’s Chief Executive Officer for Dubai and Senior Vice President for the United Arab Emirates, Oman and Bahrain. Mr. Esa has been with the Agility for eight years and is responsible for providing leadership and growing Agility’s business in Dubai.With over 15 years of experience in the transportation industry in the Middle East, Mr. Esa works closely with the CEOs of Abu Dhabi [read more] Leif Kronkvist Business Development Vice President, Agility Logistics Leif Kronkvist is Agility’s Senior Vice President of Business Development for GIL Europe. Mr. Kronkvist has been with Agility for 5 years and is responsible for business development and customer relationship management in Europe covering all modes of transportation with a special focus on Life Science. With over 20 years of experience in the transportation industry in Europe, Mr. Kronkvist has ext [read more] 11.15 Case study: Optimising channel connectivity and leveraging key partners in the value chain: Cutting your lead time in half Stream C: Supply chain leadership & strategy forum Ulf Neuhaus, Global Supply Chain Management, Bayer HealthCare Pushing towards a greater efficiency and movements towards VMI and consignment arrangements Selling the benefits both externally to our partners and internally Overcoming a lack of buying power and volume by driving closer supplier integration and collaboration Transactionary cost savings, impacts of instant data access and forecasting accuracy Practical implementation - how is it done? Starting small and building internal momentum Systems and technology platforms aiding the roll-out Not just the IT interface - but changing the entire operating model with partners Ulf Neuhaus Global Supply Chain Management, Bayer HealthCare Dr Ulf Neuhaus was entering the Bayer AG in 2006 as an internal consultant for supply chain management. He was involved inseveral projects, which had the scope to develop and implement the supply chain processes standards in the Bayer HealtCare AG. After four years he changed to the department of Global Supply Chain Management, where he is now responsible for the further enhancement of supply chai [read more]

Planning & optimisation Distribution & network designSupply chain leadership & strategy... 11.45a Panel Debate: Planning strategies to plan for and mitigate the effects of tenders Planning & optimisation James Hood, SVP Global Business Programme Owner, Mylan Eric Leiglon, Director Demand & Supply Operations, Ferring Pharmaceuticals Robert Ljoljo, Head of Supply Chain Management, Lek Robert Ljoljo, Head of Supply Chain Management, LEK How do you forecast and demand plan when operating in a tender environment? o Routine, predictable tenders vs. speculative o Patented vs. non-patented considerations – two different ballgames o What happens if you lose the tender – it’s not over yet A question of capacities – where and how to allocate Combatting the effects by more efficient long term planning and systems James Hood SVP Global Business Programme Owner, Mylan For the best part of ten years James (Jim) Hood spent his time creating Global Supply Chain Management functions within the Generics Pharmaceutical industry. Since April 2011, Jim’s role has been Global Business Programme Owner for the Global ERP roll-out, to over 30 ComOps Affiliates and 20 Manufacturing Sites worldwide. Defining core business processes, and overseeing the implementation of a Bus [read more] Eric Leiglon Director Demand & Supply Operations, Ferring Pharmaceuticals Eric Leiglon is in charge, since 2008, of Ferring’s Demand & Supply Operations organization with global responsibility for Demand Management, Supply Planning and Customer Services activities. He is running the Sales & Operations Planning for the group and related sub processes (e.g. MPS at production site level). He is also the Global Process Owner for the Supply Ch [read more] Robert Ljoljo Head of Supply Chain Management, Lek Robert Ljoljo is director of Supply Chain Management for company LEK d.d., member of Sandoz group. He is responsible for supply chain of Sandoz Slovenian manufacturing operations and for Commercial supply chain in several countries in South Eastern and Central Europe, for which distribution is managed out of Slovenia. He is member of Sandoz Global Supply Chain team. Robert holds Masters of science [read more] Robert Ljoljo Head of Supply Chain Management, LEK 11.45 Supply Chains in the Pharmaceutical Industry: a Management topic Distribution & network design Martin Eckert, Managing Director, Miebach Consulting Summary of the European Pharma Study 2012, conducted by Miebach Consulting: Supply Chain Trends & Topics in the Pharmaceutical & Life Science Industry o Trends and benchmarks of the Pharma Supply Chain Recommendations of actions o End-to-End Supply Chain Management: the company culture changes from a research driven and production driven company to a supply chain oriented company with strong focus on costumers. o Supply Chain Visibility – a great challenge for the Pharma supply chain. o Supply Chain Design – how to optimize transport, inventory and infrastructure costs o Lean Supply Chain Management – the method to reduce the processing time Martin Eckert Managing Director, Miebach Consulting Martin Eckert has been with Miebach Consulting for over 20 years and a long-standing experience both in Supply Chain Management and Material Handling Engineering, especially within the Pharmaceutical & FMCG industry. After various positions with Miebach Germany and Miebach Spain he was responsible for the development of the Miebach network in North and Latin America with today 8 of [read more] 11.45 Redefining the service offering by enhancing segmentation and channel management Supply chain leadership & strategy forum Philippe Francois, VP, Supply Chain EMEA, Baxter Healthcare Alessandro De Luca, SVP, Head of Global Supply Network Operations, Merck Group Thomas Goutay, Country Operations Director France Benelux, Baxter Healthcare Defining the channel by addressing customer processing behaviour What’s the best strategy for you? Defining: o Primary objectives o Cost efficiency o Service Levels How do you set these up? Are we too segmented in some markets? Channel strategy in emerging markets Philippe Francois VP, Supply Chain EMEA, Baxter Healthcare Philippe Francois is currently the Supply Chain vice president for Baxter healthcare for the Europe Middle East and Africa region He holds a master degree in engineering and an MBA and started his career in the automotive industry in France where he acquired a solid experience in Just in time techniques. He joined the healthcare industry where he has been working for the last 15 years and acquire [read more] Alessandro De Luca SVP, Head of Global Supply Network Operations, Merck Group Alessandro has a degree in Nuclear Engineering and one in Civil Engineering both held at Rome University, La Sapienza.He is currently Senior Vice President, head of Supply Network Operations, in Merck Serono, a company belonging to the MerckGroup. He holds this position since August 2012. In 2011, he has joined Merck Serono as VP, head of Global Supply Chain.Previously, Alessandro has worked for m [read more] Thomas Goutay Country Operations Director France Benelux, Baxter Healthcare 15 years in Baxter Healthcare Supply Chain. Started in various roles in Supply Chain Planning & S&OP management at EMEA level. Since 2008, leading the customer operations in France & Benelux, in charge of Customer Service, Inventory & Demand management, Transport, W&D.Member of the Senior Management Team of France-Bene [read more]

Planning & optimisationDistribution & network designSupply chain leadership & strategy... 12.15 Case study: A journey to optimizing global network planning processes and systems Planning & optimisation Elisabeth Kaszas, Director, Supply Chain, Amgen Rapid expansion of our product portfolio, dynamic market demand, changing manufacturing network and long cycle times required Amgen to transform its planning organization. Our journey began four years ago with supply planning, expiry and scenario management. It relied on regional, site and corporate planning process redesign as well as the global use of an integrated advanced planning system, RapidResponse from Kinaxis. We have since expanded its use into multi-country unit forecast generation and consolidation, which permit optimized allocation of constrained capacity to dynamic markets. These foundational capabilities enabled a more efficient Sales & Operations Planning process which now drives more conscious and value-driven business decisions. Additional expansion projects have relied on RapidResponse and included the development of a Product Information Database that facilitates collaboration between Supply Chain, Regulatory and Commercial on product life cycle events, integration of non conformance information to supply planning for immediate impact assessment, as well as the valuation of WIP inventory for financial analysis. Today with the help of RapidResponse we are in the process of deploying Jurisdictional Control to better plan and control supply distribution to markets. Join me as I share our journey so far, and what’s up next. Elisabeth Kaszas Director, Supply Chain, Amgen Elisabeth Kaszas has worked at Amgen Sales & Marketing, Operations, and Supply Chain Management for the past 17 years. She has experience with both the clinical and commercial supply chain functions of biopharmaceuticals. She recently led the implementation of North America supply chain, demand and supply planning and inventory management. She previously led the global design and i [read more] 12.15 Combating the margin decline: Global distribution cost avoidance strategies for mature markets Distribution & network design Defining our key internal activities – what can be out-sourced to maximise value-add Revisiting the distribution channel o Critical: Conducting a cost-to-serve analysis on each, and of the available delivery options o What are the different needs of the end-patient – taking a totally different approach to distribution  o Capitalising on volumes by expanding the reach above and beyond even the formal health care infrastructure o The requirement of collaboration with stakeholders in the system to reach beyond tier 1 / tier 2 cities in growth markets Culling complexity from the supply chain – to what degree does this impact on costs and where are the areas that we can have a direct impact? The shift towards ocean-freight and agility impacts 12.15 Workshop: A practical route to segmentation within the supply chain Supply chain leadership & strategy forum John Sewell, Principal, Crimson & Co Kerry Pickstone, Head of Life Science, Crimson & Co Downward pressure on costs set against remorseless increases in market and customer demands is the central conflict for the end-to-end management of the supply chain. Too often this results in top-down programmes which look great at the strategy end but are turning out to be deeply unsatisfactory with poor benefits, dissatisfied markets and painfully slow implementation. There are many ways of segmenting the supply chain – simple ‘lean versus agile’ solutions barely start to recognise the real challenges of what will make a difference. So how should these segments be recognised, energised and measured? This workshop will outline a new, rigorous approach to effective segmentation strategies that will have impact in your business. John Sewell Principal, Crimson & Co John Sewell is a Principal with the UK's leading end to end supply chain consultancy, Crimson & Co. Previously he was SvP of Global Planning and Logistics at Reckitt Benckiser; designer of retailer supply chain networks, and specialist in retail and consumer goods supply chain with PricewaterhouseCoopers and others Sector experience ranges over FMCG, retailing, pharmaceuticals and [read more] Kerry Pickstone Head of Life Science, Crimson & Co Kerry Pickstone is a Managing Consultant with the UK's leading end to end supply chain consultancy, Crimson & Co. Previously she worked with Australia’s largest retailer Coles Myer in a number of roles, developing network capacity, driving operational improvement, and later managing the Sales and Operations Planning process for the non-food division. A specialist in leading change [read more]

Networking LunchSpeakers Corner 13.00 Networking Lunch Networking Lunch Networking Lunch 13.00 Speakers Corner Speakers Corner An area dedicated to interaction with the previous session’s speakers and panellists. This is your opportunity to network and speak openly and candidly about any questions not covered during their session.

Planning & optimisationDistribution & network designSupply chain leadership & strategy... 14.15 Case study: Pharma: one efficiency, more than one Supply Chain Planning & optimisation Henri Seroux, Senior Director, Manhattan Associates While healthcare distributors & pharmaceutical manufacturers have squeezed out all the costs they could by leveraging inventory, transportation and warehousing systems, the recent recession exposed the limitations of these benefits for what they wereó subcomponents optimized within the narrow confines of ìsiloedî thinking, where each department operates autonomously. They have come to realize that growing channel conflicts and challenging macroeconomic trends, along with demanding customer service levels, will continue to erode their margins. The only path to a margin-rich future requires a basic change in thinking and a cultural sea change. If you are willing to take that road, here are the four facets of change that we would like to share with you: Changing Mindsets ñ think platform for better supply chain efficiency One version of the truth ñ global supply chain visibility for better compliance and traceability Shared Decision-making Engines in optimized and collaborative supply chain Supply chain Finance ñ how Total cost to serve can now be part of your supply chain execution processes This presentation will be illustrated by customer case studies. Live customer testimonial to be confirmed. Henri Seroux Senior Director, Manhattan Associates Henri Seroux founded and manages Manhattan Associates Paris based office since its introduction on the market in 2002. Passionate about business development, he has overall responsibility to grow the Manhattan team and develop the network of clients. Before joining Manhattan, Henri ran his own business consulting firm specialising in the impact of technology and logistics on business performance a [read more] 14.15 Panel debate: Distribution consolidation: Everyone is doing it, but does it bring real value and optimisation? Distribution & network design Frank Binder, Senior Director International Logistics & Supply Chain, Celgene Kristian Sibilitz, VP, Global Supply Chain, H. Lundbeck A/S Ronald Van Zitteren, Senior Director, Head of Global Distribution & Logistics, UCB Pharma Johan Beukema, Partner for Healthcare Supply Chains, Buck Consultants International Panel debate: Distribution consolidation: Everyone's doing it, but does it bring real value and optimisation? Key drivers for consolidation o Is cost reduction the real added value? o How important is End to end control? o Reducing complexity and inventory Different strokes for different folks: What does consolidation actually look like? Not for everyone: why you should not consolidate From plan to practice: how to manage the transition? Moderated by Johan Beukema, Partner, Buck Consultants International Frank Binder Senior Director International Logistics & Supply Chain, Celgene Frank Binder is Senior Director, International Logistics and Supply Chain, at Celgene, based in Switzerland. Currently his main task is growing and managing Celgene’s international pharmaceutical Supply Chain, optimizing the European distribution network while expanding the distribution network across Asia. He is guided by his team’s mission statement “Products to the Patients – Every Time, On Tim [read more] Kristian Sibilitz VP, Global Supply Chain, H. Lundbeck A/S Kristian Sibilitz, MSc in Engineering, has since 2009 been responsible for Logistics at H. Lundbeck A/S, encompassing new product introduction in the supply chain, direct purchasing, contract manufacturing, artwork management, production planning, product costing, warehousing and distribution. Prior to this, Kristian worked with planning, before taking responsibility for Lundbeck’s supply chain st [read more] Ronald Van Zitteren Senior Director, Head of Global Distribution & Logistics, UCB Pharma Ronald is a Dutchman and has spent 20 years in multinational industrial environments covering assignments in LifeSciences with Zeneca, GE, Amgen and the last 5 years at UCB. Being a marketeer from origin he started his career in sales and marketing roles but spend the past roughly 16 years in supply chain positions. He has managed all functional areas like purchasing, planning, forecasting and dem [read more] Johan Beukema Partner for Healthcare Supply Chains, Buck Consultants International Johan Beukema is Partner for Healthcare Supply Chains at Buck Consultants International. As a Partner and co-owner of the company he is responsible for BCI’s activities in the pharma, biotech and medical devices industries. Johan holds a degree in Business Administration of the University of Groningen in The Netherlands, did part of his studies at the Business School of the University of Tampere, [read more] 14.15 A tailor-made discussion forum designed for and limited to supply chain VPs Supply chain leadership & strategy forum Jolyon Austin, Managing Director, Life Sciences Supply Chain, Accenture Points for discussion and debate: How can we approach the transformation of life sciences’ traditional supply chains into dynamic and segmented end-to-end value chains that fully align with and enable the company’s business strategy and act as engines of financial growth? How is the definition of the customer evolving both at a macro level and a micro level? What is meant by segmentation, and how is it applied in practical terms? What are the opportunities for supply chains to become differentiators and enablers of margin growth in both mature and emerging markets? See full details on the website: www.wbresearch.com/logipharmaeurope/thinktank.aspx {Br}2013 Moderator: Jolyon Austin, Managing Director, Life Sciences Supply Chain, Accenture Confirmed participants: SVP, Head of Global Supply Network Operations, Merck Group Head of Global Supply Chain Planning, AstraZeneca Global Supply Chain Director, Process Stewardship, Bristol Myers Squibb Senior Director - Supply Chain Leader Alliance, Pfizer Vice President EMEA Supply Chain Operations, Pfizer Europe Supply Chain Business Director, GlaxoSmithKline Global VP, Supply Chain, Ferring Pharmaceuticals Executive Director, Supply Chain Strategy, Teva SVP Head of Global Supply Chain Management, Teva VP Global Distribution and Logistics, GenzymeVP Global Supply Chain, UCB Pharma VP, Supply Chain EMEA, Baxter Healthcare SVP Supply Chain, Merck & Co.Corporate Vice President SCM, Boehringer Ingelheim Jolyon Austin Managing Director, Life Sciences Supply Chain, Accenture Jolyon Austin leads Accenture’s Europe, Middle East and Africa Life Sciences Supply Chain Practice. He works with clients to define and realise sustainable step changes in supply chain performance – partnering with them on the journey from definition of an operating strategy through to on-the-ground implementation and realisation of the business case. Jolyon has extensive experience of supply chai [read more]

Planning & optimisation Distribution & network designSupply chain leadership & strategy... 15.00 S&OP: Cutting through the marketing hype to make this work Planning & optimisation Peter Smith, Director, Planning & Deployment EMEA, Baxter Healthcare Kerry Pickstone, Head of Life Science, Crimson & Co How can we change? o Rethinking KPI usage o It’s not just the tools, but also the people - organisational design for success o Making choices on do we need to deliver everything to everyone Building flexibility into a global rollout – do you need the have the same system everywhere? o What this means for new markets  Re-invigorating the process to combat natural degradation Reconciling from regional to global  Integrating the customer’s perspective and access considerations Peter Smith Director, Planning & Deployment EMEA, Baxter Healthcare Peter Smith is Supply Chain Director for Baxter Healthcare EMEA, responsible for demand forecasting, manufacturing capacity planning and inventory management. Peter has had numerous roles in supply chain planning during his 18 year period with Baxter, with the last 4 being located out of the EMEA headquarters in Zurich. Peter has a Master’s degree in Supply Chain Management from Cranfield Universi [read more] Kerry Pickstone Head of Life Science, Crimson & Co Kerry Pickstone is a Managing Consultant with the UK's leading end to end supply chain consultancy, Crimson & Co. Previously she worked with Australia’s largest retailer Coles Myer in a number of roles, developing network capacity, driving operational improvement, and later managing the Sales and Operations Planning process for the non-food division. A specialist in leading change [read more] 15.00 Transportation innovation and collaboration showcase: Collaboration opportunities in Pharma to exploit value in the disribution chain Distribution & network design Jean-François Fusco, Chairman, EALTH (European Association for Logistics and Transport in Healthcare) Tommy Weston, Division Director, PLAN Europe Martijn Lofvers, Owner of Supply Chain Media, Supply Chain Media Collaboration opportunities in Pharma to exploit value in the distribution chain PLAN: Increasing and complex demands in an ever changing world for the pharmaceutical industry Tommy Weston, Division Director, PLAN Europe EALTH: A responsiveness organization in the EU Dr Jean Francois Fusco, President, EALTH Supply Chain Mind Mapping: making sense of global trends Martijn Lofvers, Publishing Director & Editor-in-Chief, Supply Chain Movement Jean-François Fusco Chairman, EALTH (European Association for Logistics and Transport in Healthcare) Doctor in Pharmacy plus business school, Jean-François has spent 10 years in a pharmaceutical company as Supply Chain Manager and Deputy Pharmacist. After 4 years in merchant banking as responsible for a portfolio of subsidiaries and participations, he started a career in the Healthcare LSP with different positions : Operations Director, Project Director, and since 2008 Europe Pharmaceutical Gener [read more] Tommy Weston Division Director, PLAN Europe Tommy Weston is the director of the international division of Bech-Hansen & Studsgaard with branches in Copenhagen and Aarhus. He is also responsible for the development of the European partner network and the sales organization. Apart from his position at BHS, he is also managing Director and boardmember of the co-owned company Nordic Chain AB and boardmember of the co-owned compa [read more] Martijn Lofvers Owner of Supply Chain Media, Supply Chain Media Martijn Lofvers is owner of Supply Chain Media and founder of the Dutch Supply Chain Magazine (in 2006) and the European quarterly magazine Supply Chain Movement (in 2011). The mission of Supply Chain Media is to connect supply chain professionals worldwide and provide them with strategic knowledge to use in their daily practice. Supply Chain Media is one of the few international media companies s [read more] 15.00 VP Think Tank (continued) Supply chain leadership & strategy forum (Please see above) Full details also available on the website: www.wbresearch.com/logipharmaeurope/thinktank.aspx

Afternoon coffee and networkingSpeakers Corner 15.30 Afternoon coffee and networking Afternoon coffee and networking Afternoon coffee and networking 15.30 Speakers Corner Speakers Corner An area dedicated to interaction with the previous session’s speakers and panellists. This is your opportunity to network and speak openly and candidly about any questions not covered during their session.

16.00 Balancing on-site and offshore services for supply chain management systems including a customer case study Markus Ernst, Head of IS Business Partnering Enabling Functions GBS, Boehringer Ingelheim Andreas Doerner, Senior Partner, Managing Director, CNT Management Consulting Balancing on-site and offshore services for supply chain management systems including a customer case study Markus Ernst Head of IS Business Partnering Enabling Functions GBS, Boehringer Ingelheim Markus Ernst has been with Boerhinger Ingelheim since 1995 in his current postion, he is Head of IS Business Partnering Enabling Functions GBS based in Germany and he currently leads the SAP ERP Boehringer deplyoments worldwide from the IS perspective. He has over 15 years experience in the areas of supply chain, financial and controlling processes within SAP ERP implementation projects in the pha [read more] Andreas Doerner Senior Partner, Managing Director, CNT Management Consulting Andreas is founder and managing director of CNT Management Consulting, a global management consultancy focusing on ERP strategies and solutions for the pharmaceutical and engineering industry. The company is specialized on driving business value through system consolidation programs, optimizing and transforming of supply chain processes and enabling global IT-solutions. The career has been focused [read more]

16.30 The interface between commercial and supply chain debate: Hillel West, Executive Director, Operations and Supply Chain Strategy, Teva Pharmaceuticals Dirk Schrader, Senior VP, Head Industrial Operations, Vifor Pharma John Sewell, Principal, Crimson & Co Motion: The house believes that the supply chain function does not fully fulfil the needs of the organisation Competing perspectives and what do they expect from us? Solid fact-based decision making vs. flexibility and capitalising on new opportunities ñ reconciling the need for efficiency and opportunism Balancing portfolio rationalisation with market access and the needs of commercial Where can both bring value to the customer by working together closely and overcoming silo mentalities Moderator: John Sewell, Managing Consultant, Crimson & Co For the motion: Dirk Shcrader, Senior VP, Head Industrial Operations, Vifor Pharma Against the motion: Hillel West, Executive Director, Operations and Supply Chain Strategy, Teva Pharmaceuticals Hillel West Executive Director, Operations and Supply Chain Strategy, Teva Pharmaceuticals Hillel West is responsible for development of Operations and Supply Chain Strategy at Teva Pharmaceuticals - the world's largest supplier of generic pharmaceuticals. Teva's strategy includes the balancing of global optimisation with local accountability and a dynamic, entrepreneurial business culture. Hillel has 25 years Supply Chain experience in Pharmaceuticals and CPG, in various Supply Chain M [read more] Dirk Schrader Senior VP, Head Industrial Operations, Vifor Pharma Dirk Schrader is Head of Industrial Operations and Member of the Executive Committee for Vifor Pharma, based in St. Gallen and Zuerich/Switzerland. Vifor Pharma is a world leader in the discovery, development, manufacturing and marketing of pharmaceutical products for the treatment of iron deficiency. The company also offers a diversified portfolio of prescription medicines as well as over-the-cou [read more] John Sewell Principal, Crimson & Co John Sewell is a Principal with the UK's leading end to end supply chain consultancy, Crimson & Co. Previously he was SvP of Global Planning and Logistics at Reckitt Benckiser; designer of retailer supply chain networks, and specialist in retail and consumer goods supply chain with PricewaterhouseCoopers and others Sector experience ranges over FMCG, retailing, pharmaceuticals and [read more]

17.15 LogiPharma Industry Pulse interactive voting session: Up to the minute analysis of the latest supply chain impacts Julian Amey, Principal Fellow, Warwick University Michael Jarosch, Partner, Camelot Management Consultants AG LogiPharma Industry Pulse interactive voting session: Up to the minute analysis of the latest supply chain impacts Julian Amey Principal Fellow, Warwick University Julian Amey joined ICI in 1978 as a control engineer. He had roles in engineering, production management, and production planning (on secondment in the US). From 1991 he had responsibilities for aseptic manufacture and new product introduction. In 1994 Julian coordinated supply chain re-engineering in Zeneca Pharmaceuticals until in 1998 he headed up Zeneca’s Supply Chain Group. At the merger with [read more] Michael Jarosch Partner, Camelot Management Consultants AG Michael Jarosch joined Camelot Management Consultants in 2008 leading the Pharma and Medical Devices industry line of business and is a member of the management team at Camelot. Prior to Camelot he had positions as Vice President for Ernst & Young/Cap Gemini and as a Partner at Unisys.Michael is a top management consultant with more than 20 years of extensive experience in strategy [read more]

18.00 Strategy Focused Round-Tables Christoph Feldmann, Senior Director - Supply Chain Leader Alliance, Pfizer Michael Jarosch, Partner, Camelot Management Consultants AG Fabio Mioli, Europe Business Development Director, DHL Supply Chain Geert Robbrecht, EMEA Business Development Director, DHL Supply Chain Jacques Le Ny, Partner, Infosys Lodestone Aleksandr Kraytser, Head Channel Management RE, Novartis Michael Weidel, Director of Strategic Solutions, Infor Richard Buxton, Account Manager, Infor Mike Isles, European medicines Partnership Director, International Health Partners Anthony Dunnett, President, International Health Partners Innovative methods to deal with increasing supply chain requirements alongside higher volatility and uncertainties; Christoph Feldmann 2. Maximising the role of the Supply Chain in S&OP;  Michael Weidel & Richard Buxton Addressing change management in the life science and healthcare supply chain; Fabio Mioli & Geert Robbrecht The Eurozone in Crisis - assessing the impacts on channel management & how we can mitigate the risk whilst overcoming cash collection challenges; Aleksandr Kraytser Why Master Data is sexy and strategic; Michael Jarosch Corporate Social Responsibility - how surplus inventory from Europe can be used strategically to make a difference in under-resourced health systems; Anthony Dunnett & Mike Isles Integrating global supply chains - goals and challenges; Jacques le Ny Christoph Feldmann Senior Director - Supply Chain Leader Alliance, Pfizer Christoph is responsible for the global end-to-end distribution & supply chain and launch program for Pfizer’s Established Products Generics Segment. Before he was leading the strategic business support, the strategic planning and the strategic projects within logistics, distribution and supply for all Pfizer businesses in EMEA. An important part of his role was the EMEA-wide coord [read more] Michael Jarosch Partner, Camelot Management Consultants AG Michael Jarosch joined Camelot Management Consultants in 2008 leading the Pharma and Medical Devices industry line of business and is a member of the management team at Camelot. Prior to Camelot he had positions as Vice President for Ernst & Young/Cap Gemini and as a Partner at Unisys.Michael is a top management consultant with more than 20 years of extensive experience in strategy [read more] Fabio Mioli Europe Business Development Director, DHL Supply Chain Fabio Mioli is Director, Business Development Life Sciences and Healthcare (LSHC), DHL Supply Chain EMEA. He joined DHL in November 2010 from Wyeth Pharmaceutical, where he was responsible for Supply Chain and Commercial Operations, including sales forecasting, distribution and trade, mature product portfolio and hospital tender management. Prior to that Fabio worked for the pan-European pharmaceu [read more] Geert Robbrecht EMEA Business Development Director, DHL Supply Chain Geert Robbrecht is Director of Business Development for the Life Sciences and Healthcare sector across Europe, Middle East and Africa (EMEA) for DHL Supply Chain. Geert has been in this role since March 2011 and his principle responsibilities include supporting healthcare companies to set up and optimize their supply chains in the EMEA region. Geert has worked for DHL for over ten years, starting [read more] Jacques Le Ny Partner, Infosys Lodestone Jacques’s is specialized in supply chain planning & collaboration. He holds a master degree in information processing and started his career during 5 years in the high tech industry as a qualified electronics engineer before becoming a consultant specialized in manufacturing, just-in-time and logistics. He then focused on supply chain planning with various technologies, Numetrix, M [read more] Aleksandr Kraytser Head Channel Management RE, Novartis Aleksandr (Alex) currently leads Novartis Region Europe Channel Management team, managing commercial relationships and developing new marketing and commercial model approaches in pharmacies, hospitals and wholesaler channels. Prior to joining Novartis, Alex built up a broad base of commercial, marketing and sales experiences in the US and Europe across pharmaceutical, biotech and medical device in [read more] Michael Weidel Director of Strategic Solutions, Infor Michael Weidel has over 20 years of experience in software and manufacturing companies, where he has held various positions including product management, professional services, business consultancy, and sales. Today, he is account manager for the Infor supply chain management solutions, which include Sales & Operations Planning, Demand planning, manufacturing planning and schedulin [read more] Richard Buxton Account Manager, Infor Richard Buxton has been with Infor for over 12 years and during this time has focussed on working with life science clients on implementing Infor’s Integrated Business Planning suite to assist in the unique challenges faced within this industry. These projects range from Global to Pan European to Country specific projects and range from end to end IBP projects to Demand Planning centric projects t [read more] Mike Isles European medicines Partnership Director, International Health Partners Mike is European Medicines Partnership Director for International Health Partners (www.ihpuk.org), a UK charity whose Queen’s Award for Enterprise and Innovation in 2011, recognises the tremendous humanitarian work sourcing donated medicines from the pharmaceutical industry and coordinating delivery via secure supply chain solutions to disaster-struck areas in close liaison with NGOs. Currently, M [read more] Anthony Dunnett President, International Health Partners Anthony Dunnett is President of International Health Partners (IHP), a unique not-for-profit partnership with the global healthcare industry that aims to increase access to medicine and improve health in the developing world. As the charity’s founder, Anthony is responsible for the rapid growth of the enterprise and its strategic alliance with some of the world’s largest pharmaceutical manufacture [read more]

18.45 Chairperson's closing remarks, followed by drinks reception Chairperson's closing remarks, followed by drinks reception

19.00 - 20:30 Invitation Only Drinks Reception in the Glowing Room - Hosted by: Infosys Lodestone Join us in the Glowing Room for an evening of indulgence hosted by Lodestone. Sample 5 ‘Grand Cru’ Chocolates with their perfect wine pairing under the guidance of the resident 5* Pastry Chef. Alongside this, we have a local sommelier onsite keen to impress you with his selection of regional wines.